Director of CMC and Technical Operations

Naveen Mallampati is an accomplished biopharmaceutical leader with over two decades of experience guiding complex drug products from development to commercialization. As Director of Chemistry, Manufacturing, and Controls (CMC) and Technical Operations at MedPharm, Mr. Mallampati leads cross-functional initiatives that strengthen the company’s pharmaceutical development, manufacturing, and supply chain capabilities.

With a strong focus on operational excellence and innovation, Mr. Mallampati is driving MedPharm’s strategic expansion into late-stage clinical development, regulatory submissions, and commercial product launches. His leadership is central to building GMP-compliant infrastructure, enhancing technical capabilities, and ensuring successful navigation of regulatory inspections.

Prior to joining MedPharm, Mr. Mallampati held leadership roles at leading pharmaceutical organizations including Tergus Pharma, Akorn, CPL, Patheon, Natco Pharma, and Dr. Reddy’s. His expertise spans product selection and lifecycle management, development optimization, and global commercialization strategies—all aimed at improving profitability and long-term growth.

Mr. Mallampati holds a Bachelor of Science in Pharmacy and an MBA with a focus in Pharmaceutical Management. He brings a unique blend of technical depth and business insight to MedPharm’s mission of delivering high-quality, innovative therapies to patients.